Lithium Bests Newer Drugs for Bipolar Disorder

While it has been around for decades to treat bipolar disorder, the drug lithium works better than newer -– and more expensive –- mood stabilizers in terms of lower rates of self-harm and unintended injury.

Researchers led by Joseph F. Hayes, MSc, MB, ChB, of University College London, looked at rates of self-harm, unintentional injury and suicide deaths in patients prescribed lithium, Depakote (valproate), Zyprexa (olanzapine) or Seroquel (quetiapine). They examined electronic health records of more than 6,671 individuals diagnosed with bipolar disorder and given one of the drugs.

Overall, people who were not taking lithium and were on one of the other mood stabilizers were 40% more likely have harmed themselves in comparison to those on lithium, according to results published in JAMA Psychiatry. Also, those on Depakote were 32% to 34% more likely to sustain an unintended injury.

The finding “supports the hypothesis that lithium use reduces impulsive aggression in addition to stabilizing mood,” the study authors conclude, reinforcing lithium as the “gold standard” in the treatment of bipolar disorder.

However, lithium itself is not without side effects. These include a risk of kidney disease and hypothyroidism, or an underactive thyroid gland. As a result, people on lithium are often required to undergo lab tests every 3 to 6 months to make sure their kidneys are functioning correctly.

Lithium is also far cheaper than the other drugs examined in the study. For example, a 2008 studyfound that Zyprexa is $500 more expensive per month than lithium.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?

No votes so far! Be the first to rate this post.


Latest News

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

Flouride, PPIs, Breast Density and Prostate Cancer

Flouride, PPIs, Breast Density and Prostate Cancer

Startling news about fluoride, a study encourages more limites use of PPIs, does knowing the density of your breasts matter, and vegetables aren’t helpful in warding off prostate cancer (darn).  Be Well.  Fluoride and Pregnancy The medical community was shocked at the conclusions of two new studies on fluoride’s effect…

  • Advertisement